A detailed history of Northwest & Ethical Investments L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 611,943 shares of PFE stock, worth $14.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
611,943
Previous 209,453 192.16%
Holding current value
$14.8 Million
Previous $5.31 Billion 179.48%
% of portfolio
0.37%
Previous 0.14%

Shares

57 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$21.59 - $24.84 $8.69 Million - $10 Million
402,490 Added 192.16%
611,943 $14.8 Billion
Q1 2025

May 13, 2025

SELL
$25.01 - $27.13 $1.39 Million - $1.51 Million
-55,619 Reduced 20.98%
209,453 $5.31 Billion
Q4 2024

Feb 11, 2025

BUY
$24.8 - $30.19 $38,216 - $46,522
1,541 Added 0.58%
265,072 $7.03 Billion
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $216,032 - $244,810
7,799 Added 3.05%
263,531 $7.63 Billion
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $6.46 Million - $7.57 Million
255,732 New
255,732 $7.16 Billion
Q1 2024

Jul 09, 2025

BUY
$25.89 - $29.73 $683,418 - $784,782
26,397 Added 12.6%
235,850 $6.54 Billion
Q4 2023

Jul 09, 2025

BUY
$26.13 - $33.94 $667,177 - $866,590
25,533 Added 7.0%
390,179 $11.2 Billion
Q3 2023

Jul 09, 2025

BUY
$32.09 - $37.51 $4.53 Million - $5.29 Million
141,058 Added 63.09%
364,646 $12.1 Billion
Q2 2023

Jul 09, 2025

BUY
$36.12 - $41.79 $2.38 Million - $2.76 Million
65,941 Added 41.83%
223,588 $8.2 Billion
Q1 2023

Jul 09, 2025

BUY
$39.39 - $51.28 $542,282 - $705,971
13,767 Added 9.57%
157,647 $6.43 Billion
Q4 2022

Jul 09, 2025

SELL
$41.75 - $54.5 $2.99 Million - $3.9 Million
-71,620 Reduced 33.23%
143,880 $7.37 Billion
Q3 2022

Jul 09, 2025

BUY
$43.76 - $53.42 $440,706 - $537,992
10,071 Added 4.9%
215,500 $9.43 Billion
Q2 2022

Jul 09, 2025

BUY
$46.53 - $55.17 $3.68 Million - $4.36 Million
79,027 Added 62.52%
205,429 $10.8 Billion
Q1 2022

Jul 09, 2025

SELL
$45.75 - $56.69 $3.8 Million - $4.71 Million
-83,051 Reduced 39.65%
126,402 $6.54 Billion
Q4 2021

Jul 09, 2025

BUY
$41.32 - $61.25 $4.59 Million - $6.81 Million
111,178 Added 157.91%
181,583 $10.7 Billion
Q3 2021

Jul 09, 2025

BUY
$39.25 - $50.42 $632,356 - $812,316
16,111 Added 29.67%
70,405 $3.03 Billion
Q2 2021

Jul 09, 2025

SELL
$35.91 - $40.68 $2.67 Million - $3.03 Million
-74,370 Reduced 57.8%
54,294 $2.13 Billion
Q1 2021

Jul 09, 2025

SELL
$33.49 - $37.77 $2.71 Million - $3.05 Million
-80,789 Reduced 38.57%
128,664 $4.66 Billion
Q4 2020

Jul 08, 2025

SELL
$33.47 - $42.56 $201,388 - $256,083
-6,017 Reduced 6.36%
88,550 $3.26 Billion
Q3 2020

Jul 08, 2025

SELL
$31.75 - $37.25 $35,020 - $41,086
-1,103 Reduced 1.15%
94,567 $3.47 Billion
Q2 2020

Jul 08, 2025

BUY
$30.12 - $36.54 $126,865 - $153,906
4,212 Added 4.61%
95,670 $3.13 Billion
Q1 2020

Jul 08, 2025

SELL
$27.03 - $38.62 $2.02 Million - $2.88 Million
-74,681 Reduced 44.95%
91,458 $2.99 Billion
Q4 2019

Jul 08, 2025

BUY
$32.92 - $37.36 $2.29 Million - $2.6 Million
69,662 Added 72.21%
166,139 $6.51 Billion
Q3 2019

Jul 08, 2025

BUY
$32.49 - $42.13 $133,241 - $172,775
4,101 Added 4.44%
96,477 $3.47 Billion
Q2 2019

Jul 08, 2025

SELL
$36.98 - $41.52 $3.07 Million - $3.45 Million
-83,112 Reduced 47.36%
92,376 $4 Billion
Q1 2019

Jul 08, 2025

BUY
$37.5 - $41.2 $224,212 - $246,334
5,979 Added 3.53%
175,488 $7.45 Billion
Q4 2018

Jul 08, 2025

SELL
$38.47 - $43.86 $1.54 Million - $1.75 Million
-39,944 Reduced 19.07%
169,509 $7.4 Billion
Q3 2018

Jul 08, 2025

BUY
$34.47 - $41.81 $77,557 - $94,072
2,250 Added 1.53%
149,429 $6.59 Billion
Q2 2018

Jul 08, 2025

BUY
$32.98 - $35.16 $1.56 Million - $1.66 Million
47,224 Added 47.25%
147,179 $5.34 Billion
Q1 2018

Jul 08, 2025

BUY
$31.91 - $37.02 $1.27 Million - $1.47 Million
39,766 Added 66.07%
99,955 $3.55 Billion
Q4 2017

Jul 08, 2025

SELL
$33.26 - $35.29 $185,923 - $197,271
-5,590 Reduced 8.5%
60,189 $2.18 Billion
Q3 2017

Jul 08, 2025

BUY
$31.0 - $34.15 $132,370 - $145,820
4,270 Added 6.94%
65,779 $2.36 Billion
Q2 2017

Jul 08, 2025

SELL
N/A
-5,660 Reduced 8.43%
61,509 $2.07 Billion
Q1 2017

Jul 08, 2025

BUY
N/A
14,910 Added 28.53%
67,169 $2.3 Billion
Q4 2016

Jul 08, 2025

SELL
N/A
-107,791 Reduced 67.35%
52,259 $1.7 Billion
Q3 2016

Jul 08, 2025

SELL
N/A
-49,403 Reduced 23.59%
160,050 $5.42 Billion
Q2 2015

Jul 08, 2025

SELL
N/A
-157,000 Closed
0 $0
Q1 2015

Jul 08, 2025

SELL
N/A
-1,400 Reduced 0.88%
157,000 $5.46 Billion
Q4 2014

Jul 08, 2025

BUY
N/A
158,400 New
158,400 $4.93 Billion
Q4 2013

Jul 08, 2025

SELL
N/A
-406,290 Closed
0 $0
Q3 2013

Jul 08, 2025

BUY
N/A
19,615 Added 5.07%
406,290 $11.7 Billion
Q2 2013

Jul 08, 2025

SELL
N/A
-40,065 Reduced 9.39%
386,675 $10.8 Billion
Q1 2013

Jul 08, 2025

BUY
N/A
217,287 Added 103.74%
426,740 $12.3 Billion
Q4 2012

Jul 07, 2025

SELL
N/A
-21,215 Reduced 5.28%
380,560 $9.54 Billion
Q3 2012

Jul 07, 2025

SELL
N/A
-396,470 Reduced 49.67%
401,775 $9.98 Billion
Q2 2012

Jul 07, 2025

BUY
N/A
182,995 Added 29.74%
798,245 $18.4 Billion
Q1 2012

Jul 07, 2025

BUY
N/A
35,805 Added 6.18%
615,250 $13.9 Billion
Q4 2011

Jul 07, 2025

SELL
N/A
-24,110 Reduced 3.99%
579,445 $12.5 Billion
Q3 2011

Jul 07, 2025

BUY
N/A
14,900 Added 2.53%
603,555 $10.7 Billion
Q2 2011

Jul 07, 2025

BUY
N/A
43,880 Added 8.05%
588,655 $12.1 Billion
Q1 2011

Jul 07, 2025

BUY
N/A
335,322 Added 160.09%
544,775 $11.1 Billion
Q4 2010

Jul 03, 2025

BUY
N/A
25,885 Added 4.87%
557,235 $9.76 Billion
Q3 2010

Jul 03, 2025

BUY
N/A
8,500 Added 1.63%
531,350 $9.12 Billion
Q2 2010

Jul 03, 2025

BUY
N/A
64,950 Added 14.18%
522,850 $7.46 Billion
Q1 2010

Jul 03, 2025

BUY
N/A
16,600 Added 3.76%
457,900 $7.85 Billion
Q4 2009

Jul 03, 2025

SELL
N/A
-43,000 Reduced 8.88%
441,300 $8.03 Billion
Q3 2009

Jul 03, 2025

BUY
N/A
274,847
484,300 $8.02 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $136B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.